Press Releases

(BIO) announced the industrial biotechnology companies selected to present their technology development and business models to investors and analysts at BIO’s 9th annual World Congress on Industrial Biotechnology and Bioprocessing.

The Biotechnology Industry Organization expressed strong support for the signing of the Jumpstart Our Business Startups (JOBS) Act into law today.

BIO joined 100 renewable energy, energy efficiency, farm, ranch, commodity, environmental, and other groups in a letter to the leaders of the House and Senate Agriculture Committees asking for reauthorization and funding of Farm Bill energy title programs.

Executives from brand-name consumer product companies will discuss the strategies for adoption of industrial biotech innovations in plenary and breakout sessions at BIO’s 9th annual World Congress on Industrial Biotechnology and Bioprocessing.

Centric Health Resources and the National Organization for Rare Disorders (NORD), Co-organizersAlnylam Pharmaceuticals, Genzyme, a Sanofi Company and Millennium: The Takeda Oncology Company, Co-sponsors

Domestic biofuel production is necessary for energy and national security, the Biotechnology Industry Organization (BIO) emphasized today in a letter to the leaders of the House Armed Services Committee and its Subcommittee on Readiness. 

Sara Radcliffe, Executive Vice President of Health at the Biotechnology Industry Organization (BIO), testified today on biosimilar user fees (BsUFA) and the Prescription Drug User Fee Act (PDUFA) before the Senate Health, Education, Labor and Pensions Committee.

BIO has named Steen Riisgaard as the recipient of its 2012 George Washington Carver Award for innovation in industrial biotechnology.

Annual Award to Recognize Innovator Who Is Transforming Society byHelping to Heal, Feed or Fuel the World 

The JOBS Act will incentivize and encourage capital formation for growing companies, and spur job growth in the U.S.  

Today, a group of biofuel and renewable energy organizations released a letter to Congressional leaders asking them to continue to fully support the Renewable Fuel Standard.  

The Biotechnology Industry Organization (BIO) applauds the Senate on the passage of H.R. 3606, the Jumpstart Our Business Startups (JOBS) Act.

“With continuous advances in both biomedical and food applications, we look forward to again bringing together the world’s leading industry, academic and government leaders in the fields of science and animal agriculture.”  

We are excited to bring this conference to Orlando to highlight the industry's growth, particularly in the Southeast region. 

Lobb will lead CBI’s efforts to communicate science-based information about the benefits and safety of agricultural biotechnology and its contributions to sustainable development.

The reauthorization of the Pandemic All-Hazards Preparedness Act and the Special Reserve Fund signify the solid commitment of government attention and funding which will allow the biotech industry to do even more to help protect our nation.

House passes H.R. 3606, the Jumpstart Our Business Startups (JOBS) Act.

We are excited to offer this information-packed plenary program at the 2012 World Congress where speakers will highlight how industrial biotechnology leads to innovation and new jobs while helping to build a biobased economy.

Global Event for biotechnology to be held June 18-21, 2012 in Boston, MA.

BIO applauded the House Energy and Commerce Committee’s passage of the Medicare Decisions Accountability Act, H.R. 452, which would repeal the Independent Payment Advisory Board (IPAB) established in the health care reform law.

The FAST Act will modernize the Accelerated Approval pathway to expedite the development of modern, targeted, and personalized therapies for patients suffering from serious and life-threatening diseases, while preserving the Food and Drug Administration's (FDA) robust standards for safety and effectiveness.